Verification register Bio, Health & Neuro
Current reading
Readiness band and full integer triple
AI-assisted assembly · derived results
Readiness band
Mature
Primary summary from verified readiness
- Confidence
- 82% · stale
- Computed at
- 2026-09-22T23:27:14.984527+00:00
- Claimed
- 90
- Reported
- 89
- Verified
- 83
- Gap
- +7
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed leads verified
Evidence strength Strong
Decision
What the current evidence supports
Human editorial judgment · 2026-09-22
Adopt with guardrails
- Why
- Practice-changing Phase 3 data (first positive Phase 3 of a bispecific in myeloma) and full FDA approval put this at high maturity — but the infection/fatal-AE profile mandates real guardrails, and it is an approved drug rather than a speculative platform tech.
- Next
- Use as a reference exemplar of a mature, FDA-approved bispecific combination; apply infection-prophylaxis guardrails (IVIG + antimicrobial prophylaxis) per the MajesTEC-3 protocol amendment that reduced infection incidence.
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 6
- Tier 1
- 4
- Tier 2
- 2
- Tier 3
- 0
- Supports
- 3
- Contradicts
- 1
- Context
- 2
- Latest observed
- 2026-03-05
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Revision 2
- 2026-07-19 Reading moved from mature to mature.
- 2026-09-22 Reading moved from mature to mature.